Efficacy and Safety of MMFS in Early AD
Clinical trial NCT03531684 · COMPLETED
Trial details
- NCT number
- NCT03531684
- Sponsor
- Neurocentria, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-20
- Primary completion
- 2020-04-22
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.